The U.S. House of Representatives is expected to pass legislation today aimed at improving access to clinical trials for communities of color and decreasing health disparities.
A new bill introduced in the U.S. House of Representatives today aims to improve access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more Americans.
JACKSON, MS — November 25, 2020 — Mississippi ranks last in the nation when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer, according to the American Cance
LANSING, MI – A statement from Andrew Schepers, government relations director in Michigan for the American Cancer Society Cancer Action Network (ACS CAN) on the passing of former Sen. Tom Casperson from complications with lung cancer.
The Missoula City Council passed an ordinance to restrict the sale of flavored e-cigarettes only. The Montana chapters of the American Cancer Society Cancer Action Network (ACS CAN), American Heart Association (AHA) and American Lung Association opposed the policy because it does not include menthol cigarettes and all other flavored tobacco products, leaving opportunities for Big Tobacco to continue marketing flavored products to youth.
Washington, D.C. —The Trump administration issued a interim final rule Friday that would significantly change how Medicare pays for certain prescription drugs.
To mark the Great American Smokeout, ACS CAN is asking Governor Wolf and the state legislature to include funding in the new budget for tobacco control programs.
ACS CAN marked the Great American Smokeout by asking for increased tobacco taxes in New York State.
To mark the Great American Smokeout, ACS CAN is calling for a tobacco tax increase in Virginia.
As millions of seniors and other enrollees select their 2021 Medicare health benefits during annual open enrollment, a new report details just how confusing the program’s appeals process can be should a patient need to appeal a claim denial for health care services or prescription drugs.